Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-116345

President and CEO sold 62,720 shares at an average $27.28 ($1,711,247)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Harris Todd President and CEO 2024-10-18 Sale 10b5-1 −43,636 $27.01 $1,178,796 1,375,011 D
Harris Todd President and CEO 2024-10-21 Sale 10b5-1 −5,896 $27.32 $161,081 1,369,115 D
Harris Todd President and CEO 2024-10-21 Sale 10b5-1 −13,188 $28.16 $371,370 1,355,927 D
Open-market sales · 62,720 sh · avg $27.28 · $1,711,247
Loading xslF345X05/ownership.xml…